Physician profile
Lyssa Brooks
NPI 1184243628
$1,116.85
in general payments reported to CMS, 2019-2025
12 companies · $552 in 2025
The $552 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $82.40 · 2022: $48.72 · 2023: $141 · 2024: $293 · 2025: $552.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $986.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $985.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $250.21 | 2024-2025 | Caplyta |
| Neurelis, INC. | $165.76 | 2021-2023 | Valtoco |
| Abbvie INC. | $125.00 | 2024 | |
| Lilly USA, LLC | $124.97 | 2025 | Zepbound |
| Otsuka America Pharmaceutical, INC. | $121.84 | 2025 | Rexulti |
| Axsome Therapeutics, INC. | $118.54 | 2025 | Auvelity |
| Corium, LLC | $101.04 | 2023-2025 | Azstarys |
| Cranial Technologies, INC | $42.21 | 2021-2023 | Doc Band |
| Pfizer INC. | $18.74 | 2022 | |
| Glaxosmithkline, LLC. | $17.35 | 2024 | Bexsero, Rotarix |
| Neurocrine Biosciences, INC. | $16.95 | 2021 | |
| Lundbeck LLC | $14.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lyssa Brooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.